Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin
- Status
- UNKNOWN
- Phase
- PHASE1
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
- Status
- TERMINATED
- Phase
- PHASE1
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
- Status
- COMPLETED
- Phase
- N/A
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
- Status
- WITHDRAWN
- Phase
- PHASE2
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
- Status
- COMPLETED
- Phase
- N/A
A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
- Status
- COMPLETED
- Phase
- N/A
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2